2016
DOI: 10.1136/jmedgenet-2016-104202
|View full text |Cite
|
Sign up to set email alerts
|

Mutations in the phosphatidylinositol glycan C (PIGC) gene are associated with epilepsy and intellectual disability

Abstract: joins the list of genes in which mutations result in defective biosynthesis of GPI anchoring, manifesting by global developmental delay and seizure disorder. The lack of specific biomarker dictates exome sequencing as the diagnostic procedure of choice in similar patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
27
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 46 publications
(27 citation statements)
references
References 21 publications
0
27
0
Order By: Relevance
“…These individuals have a seizure disorder responding to anti‐epileptic drugs and severe global developmental delay or intellectual disability. ALP levels were normal …”
Section: Resultsmentioning
confidence: 99%
“…These individuals have a seizure disorder responding to anti‐epileptic drugs and severe global developmental delay or intellectual disability. ALP levels were normal …”
Section: Resultsmentioning
confidence: 99%
“…Also, rare GPIa negative cells are found in the blood and bone marrow of healthy individuals (Nafa et al, 1998;Hu et al, 2005). Germinal mutations in all but seven of the 26 GPIa pathway genes have been demonstrated to be the cause a number of genetic diseases from severe forms with multiple malformations to milder forms with intellectual disability (Kim et al, 2000;Kranz et al, 2001;Schenk et al, 2001;Garcia-Silva et al, 2004;Almeida et al, 2006;Lefeber et al, 2009;Krawitz et al, 2010Krawitz et al, , 2012Maydan et al, 2011;Barone et al, 2012;Ng et al, 2012;Thompson et al, 2012;Kvarnung et al, 2013;Chiyonobu et al, 2014;Martin et al, 2014;Nakamura et al, 2014;Nakashima et al, 2014;Ohba et al, 2014;Fujiwara et al, 2015;Ilkovski et al, 2015;Lam et al, 2015;Fleming et al, 2016;Hogrebe et al, 2016;Khayat et al, 2016;Makrythanasis et al, 2016;Edvardson et al, 2017;Johnstone et al, 2017;Nguyen et al, 2017Nguyen et al, , 2018Pagnamenta et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…In regards to the second argument for mutation in PIGA being the only event that can produce GPIa deficiency because it is the only locus where a null phenotype can be produced by a single hit that is only true for individuals who are homozygous wild type for all other genes in the GPIa pathway. However, in humans, genetic conditions are known which are the result of homozygous mutations in one of the GPIa pathway genes (PIGC, PIGG, PIGH, PIGL, PIGM, PIGN, PIGO, PIGP, PIGQ, PIGT, PIGV, PIGW, PIGY, GPAA1, DPM1, DPM2, DPM3, and MPDU1) (Kim et al, 2000;Kranz et al, 2001;Schenk et al, 2001;Garcia-Silva et al, 2004;Almeida et al, 2006;Lefeber et al, 2009;Krawitz et al, 2010;Maydan et al, 2011;Barone et al, 2012;Krawitz et al, 2012;Ng et al, 2012;Thompson et al, 2012;Kvarnung et al, 2013;Chiyonobu et al, 2014;Martin et al, 2014;Nakamura et al, 2014;Nakashima et al, 2014;Ohba et al, 2014;Fujiwara et al, 2015;Ilkovski et al, 2015;Lam et al, 2015;Fleming et al, 2016;Hogrebe et al, 2016;Khayat et al, 2016;Makrythanasis et al, 2016;Edvardson et al, 2017;Johnstone et al, 2017;Nguyen et al, 2017;Nguyen et al, 2018;Pagnamenta et al, 2018). Clearly, heterozygosity for mutations will be present in the general population for each of these genes.…”
Section: Discussionmentioning
confidence: 99%